ProShares Ultra Nasdaq Biotechnology
BIB
#2852
ETF rank
ยฃ74.27 M
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
ยฃ84.41
Share price
-4.52%
Change (1 day)
44.77%
Change (1 year)

Expense ratio and fees for ProShares Ultra Nasdaq Biotechnology (BIB)

Expense Ratio

Expense Ratio as of November 2026: 0.95%

Gross Expense Ratio

Gross Expense Ratio as of November 2026: 1.17%

Net Expense Ratio

Net Expense Ratio as of November 2026: 0.95%